Effect of silver nanoparticles on Candida albicans biofilms: An ultrastructural study

Journal of Nanobiotechnology

Volumn 13, Issue 1, 2015, Pages

  Lara, Humberto H ^a   Romero Urbina, Dulce G ^a   Pierce, Christopher ^a   Lopez Ribot, Jose L ^a   Arellano Jiménez, M Josefina ^a   Jose Yacaman, Miguel ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Biofilm formation; Candida albicans; Cell wall; Electron microscopy; Filamentation; Silver nanoparticles

Indexed keywords

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CELLS; CYTOLOGY; ELECTRON MICROSCOPY; FUNGI; METAL NANOPARTICLES; NANOPARTICLES; YEAST;

BIOFILM FORMATION; CANDIDA ALBICANS; CELL WALLS; FILAMENTATION; SILVER NANOPARTICLES;

SILVER;

SILVER NANOPARTICLE; METAL NANOPARTICLE; SILVER;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CC50; CONTROLLED STUDY; CYTOTOXICITY ASSAY; FUNGAL CELL WALL; IC50; MEMBRANE PERMEABILITY; MICROWAVE RADIATION; NONHUMAN; PHENOTYPE; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE; CHEMISTRY; DRUG EFFECTS; PHYSIOLOGY; PLANKTON; SPECTROMETRY; TEMPERATURE;

BIOFILMS; CANDIDA ALBICANS; METAL NANOPARTICLES; PHENOTYPE; PLANKTON; SILVER; SPECTROMETRY, X-RAY EMISSION; TEMPERATURE;

EID: 84949657912     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-015-0147-8     Document Type: Article

References (45)

1. Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014;10:95-105.
2. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-63.
3. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4:165rv13.
4. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41:1232-9.
5. Seddiki SML, Boucherit-Otmani Z, Boucherit K, Kunkel D. Fungal infectivities of implanted catheters due to Candida sp. Biofilms formation and resistance. J Mycol Med. 2015;25:130-5.
6. Ramage G, Saville SP, Thomas DP, López-Ribot JL. Candida biofilms: an update. Eukaryot Cell. 2005;4:633-8.
7. Pierce CG, Lopez-Ribot JL. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov. 2013;8:1117-26.
8. Uppuluri P, Pierce CG, López-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiol. 2009;4:1235-7.
9. Ramage G, Wickes BL, López-Ribot JL. Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia. 2007;164:301-6.
10. Brand A. Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol. 2012;2012:517529.
11. Pierce CG, Srinivasan A, Uppuluri P, Ramasubramanian AK, López-Ribot JL. Antifungal therapy with an emphasis on biofilms. Curr Opin Pharmacol. 2013;13:726-30.
12. Taff HT, Mitchell KF, Edward JA, Andes DR. Mechanisms of Candida biofilm drug resistance. Future Microbiol. 2013;8:1325-37.
13. Maubon D, Garnaud C, Calandra T, Sanglard D, Cornet M. Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med. 2014;40:1241-55.
14. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346-53.
15. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology. 2005;3:6.
16. Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnology. 2010;8:1.
17. Lara HH, Garza-Treviño EN, Ixtepan-Turrent L, Singh DK. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnology. 2011;9:30.
18. Vazquez-Muñoz R, Avalos-Borja M, Castro-Longoria E. Ultrastructural analysis of Candida albicans when exposed to silver nanoparticles. PLoS One. 2014;9:e108876.
19. Hwang I, Lee J, Hwang JH, Kim K-J, Lee DG. Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals. FEBS J. 2012;279:1327-38.
20. Kim K-J, Sung WS, Suh BK, Moon S-K, Choi J-S, Kim JG, Lee DG. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals. 2009;22:235-42.
21. Selvaraj M, Pandurangan P, Ramasami N, Rajendran SB, Sangilimuthu SN, Perumal P. Highly potential antifungal activity of quantum-sized silver nanoparticles against Candida albicans. Appl Biochem Biotechnol. 2014;173:55-66.
22. Wady AF, Machado AL, Zucolotto V, Zamperini CA, Berni E, Vergani CE. Evaluation of Candida albicans adhesion and biofilm formation on a denture base acrylic resin containing silver nanoparticles. J Appl Microbiol. 2012;112:1163-72.
23. Panácek A, Kolár M, Vecerová R, Prucek R, Soukupová J, Krystof V, Hamal P, Zboril R, Kvítek L. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials. 2009;30:6333-40.
24. Monteiro DR, Takamiya AS, Feresin LP, Gorup LF, de Camargo ER, Delbem ACB, Henriques M, Barbosa DB. Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases. J Prosthodont Res. 2015;59:42-8.
25. Zhu Y-J, Chen F. Microwave-assisted preparation of inorganic nanostructures in liquid phase. Chem Rev. 2014;114:6462-555.
26. Gutiérrez-Wing C, Esparza R, Vargas-Hernández C, Fernández García ME, José-Yacamán M. Microwave-assisted synthesis of gold nanoparticles self-assembled into self-supported superstructures. Nanoscale. 2012;4:2281-7.
27. Clogston JD, Patri AK. Zeta potential measurement. Methods Mol Biol. 2011;697:63-70.
28. Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 2012;14:282-95.
29. Lopez-Ribot JL. Large-scale biochemical profiling of the Candida albicans biofilm matrix: new compositional, structural, and functional insights. MBio. 2014;5:e01781-14.
30. Ayala-Núñez NV, Villegas HHL, Turrent LCI, Padilla CR. Silver Nanoparticles toxicity and bactericidal effect against methicillin-resistant Staphylococcus aureus: nanoscale does matter. NanoBiotechnology. 2009;5:2-9.
31. Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet J-B. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother. 2008;61:869-76.
32. Martinez-Gutierrez F, Boegli L, Agostinho A, Sánchez EM, Bach H, Ruiz F, James G. Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling. 2013;29:651-60.
33. Isola M, Isola R, Lantini MS, Riva A. The three-dimensional morphology of Candida albicans as seen by high-resolution scanning electron microscopy. J Microbiol. 2009;47:260-4.
34. Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3:1494-500.
35. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandel M, Andes D. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother. 2007;51:510-20.
36. Xin Y, Kynoch J, Han K, Liang Z, Lee PJ, Larbalestier DC, Su Y-F, Nagahata K, Aoki T, Longo P. Facility implementation and comparative performance evaluation of probe-corrected TEM/STEM with Schottky and cold field emission illumination. Microsc Microanal. 2013;19:487-95.
37. Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D, Martínez JP. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev. 1998;62:130-80.
38. Swathy JR, Sankar MU, Chaudhary A, Aigal S, Anshup, Pradeep T. Antimicrobial silver: an unprecedented anion effect. Sci Rep. 2014;4:7161.
39. Löffler J, Einsele H, Hebart H, Schumacher U, Hrastnik C, Daum G. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol Lett. 2000;185:59-63.
40. Ordögh L, Vörös A, Nagy I, Kondorosi E, Kereszt A. Symbiotic plant peptides eliminate Candida albicans both in vitro and in an epithelial infection model and inhibit the proliferation of immortalized human cells. Biomed Res Int. 2014;2014:320796.
41. Preparation of Silver Nanoparticles in Cellulose Acetate Polymer and the Reaction Chemistry of Silver Complexes in the Polymer. http://www.cmt.ua.ac.be/golib/nurbek/837.pdf.
42. Orta-García ST, Plascencia-Villa G, Ochoa-Martínez AC, Ruiz-Vera T, Pérez-Vázquez FJ, Velázquez-Salazar JJ, Yacamán MJ, Navarro-Contreras HR, Pérez-Maldonado IN. Analysis of cytotoxic effects of silver nanoclusters on human peripheral blood mononuclear cells "in vitro". J Appl Toxicol. 2015;35:1189-99.
43. Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet. 1984;198:179-82.
44. Pierce CG, Saville SP, Lopez-Ribot JL. High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation. Pathog Dis. 2014;70:423-31.
45. Xu M, McCanna DJ, Sivak JG. Use of the viability reagent PrestoBlue in comparison with alamarBlue and MTT to assess the viability of human corneal epithelial cells. J Pharmacol Toxicol Methods. 2015;71:1-7